Skip to main content

Table 2. Six reported cases of IFN-β-induced sarcoidosis [29,30,31,32,33,34].

From: Interferon-induced sarcoidosis with uveitis as the initial symptom: a case report and review of the literature

   Patients (n) Proportion of patients (%)
Primary diseases Multiple sclerosis 5 88.3
  Melanoma 1 16.7
Sex Male 6 33.3
  Female 2 66.7
Age of sarcoidosis onset (mean ± standard deviation) Overall: 40.2 ± 11.1 years
Men: 48.0 ± 18.4 years
Women: 36.3 ± 6.8 years
Period until onset 53.8 months
(range, 5–156 months)
Organ involvement Lung* 6 100
  Lymphadenopathy
Hilar
5 83.3
  Mediastinal 4 66.6
  Abdominal 1 16.6
  Skin, spleen Each 2 Each 33.3
  Liver 1 16.6
Therapy Discontinuation of IFN 6 100
  Oral steroid 5 83.3
  Other medicine 3 50
Outcome Resolution 4 66.7
  Improvement 1 16.6
  No change 1 16.6
  1. IFN interferon, n number
  2. *With or without mediastinal and/or hilar lymphadenopathy